Search results
Results from the WOW.Com Content Network
Ultrasound Contrast Agents: Approved in the US and Europe [8] [28] [9] [29] C 4 F 10-1.9: Bubble: Perfluorobutane: Sonazoid: Daiichi Sankyo: Ultrasound Contrast Agent: Approved in Japan, [10] available in Korea, Norway, Taiwan, and China [30] C 5 F 12: 29: Bubble and/or Droplet: Dodecafluoropentane Emulsion, DDFPe: NanO 2, NVX-108, NVX-208 ...
However, the targeted technique has not yet been approved by the FDA for clinical use in the United States. Contrast-enhanced ultrasound is regarded as safe in adults, comparable to the safety of MRI contrast agents, and better than radiocontrast agents used in contrast CT scans. The more limited safety data in children suggests that such use ...
Perflubron (INN/USAN, or perfluorooctyl bromide; brand name Imagent) is a contrast medium for magnetic resonance imaging, computer tomography and sonography. [1] It was approved for this use in the United States by the Food and Drug Administration in 1993. [2]
A contrast agent (or contrast medium) is a substance used to increase the contrast of structures or fluids within the body in medical imaging. [1] Contrast agents absorb or alter external electromagnetism or ultrasound , which is different from radiopharmaceuticals , which emit radiation themselves.
The Molecular Imaging and Contrast Agent Database or MICAD is a freely accessible online source of information on in vivo molecular imaging agents. It was established as a key component of the "Molecular Libraries and Imaging" program of the NIH Roadmap, a set of major inter-agency initiatives accelerating medical research and the development of new, more specific therapies for a wide range of ...
Gadopiclenol was approved for medical use in the United States in September 2022 by the Food and Drug Administration. [2] [12]In October 2023, the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion, recommending the granting of a marketing authorization for the medicinal product Elucirem, intended for contrast-enhanced ...
Iohexol, sold under the trade name Omnipaque among others, is a contrast agent used for X-ray imaging. [4] This includes when visualizing arteries, veins, ventricles of the brain, the urinary system, and joints, as well as during computed tomography (CT scan). [4] It is given by mouth, injection into a vein, or into a body cavity. [5]
Iopromide is an iodinated contrast medium for X-ray imaging.It is marketed under the name Ultravist which is produced by Bayer Healthcare. It is a low osmolar, non-ionic contrast agent for intravascular use; i.e., it is injected into blood vessels.